Current HIV Research
HIV and Viral Immune Diseases
Volume 20, 6 Issues, 2022
ISSN: 1873-4251 (Online)
ISSN: 1570-162X (Print)
This journal supports open access
ISSN: 1873-4251 (Online)
ISSN: 1570-162X (Print)
This journal supports open access
Contents
Current HIV Research , Volume 8 - Number 3
Hepatitis C Infection Influence on Immune Recovery in HIV-Positive Patients on Successful HAART: The Role of Genotype 3
, 8(3): 186 - 193Elena Seminari, Carmine Tinelli, Giovanni Ravasi, Diego Ripamonti, Nicoletta Ladisa, Nicoletta Marino, Laura Sighinolfi, Placido Mondello, Marco Migliorino, Giampiero Carosi and Renato Maserati
DOI: 10.2174/157016210791111070
Suboptimal Etravirine Activity is Common During Failure of Nevirapine-Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1
, 8(3): 194 - 198Babafemi Taiwo, Beth Chaplin, Sudhir Penugonda, Seema Meloni, Sulaimon Akanmu, Wadzani Gashau, John Idoko, Isaac Adewole, Robert Murphy and Phyllis Kanki
DOI: 10.2174/157016210791111098
Comparison of the Expression and Immunogenicity of Wild-Type and Sequence-Modified HIV-1 gag Genes in a Recombinant Sendai Virus Vector
, 8(3): 199 - 206Shuangqing Yu, Xia Feng, Tsugumine Shu, Tetsuro Matano, Mamoru Hasegawa, Xiaoli Wang, Hongxia Li, Zelin Li, Rugang Zhong and Yi Zeng
DOI: 10.2174/157016210791111133
Psychological Predictors of High-Risk Sexual Behaviour and Drug Use among Adolescents in Georgia
, 8(3): 207 - 211Robin B. Goodwin, Iago Kachkachishvili, George Nizharadze and Duncan Cramer
DOI: 10.2174/157016210791111115
Determinants of Smoking Cessation Attempts Among HIV-Infected Patients: Results from a Hospital-Based Prospective Cohort
, 8(3): 212 - 217Gaelle Encrenaz, Antoine Benard, Virginie Rondeau, Fabrice Bonnet, Estibaliz Lazaro, Didier Neau, Michel Dupon, Francois Dabis, Patrick Mercie and Genevieve Chene
DOI: 10.2174/157016210791111089
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection
, 8(3): 218 - 222Massimiliano Lanzafame, Umberto Tirelli, Lorenza Guella, Annalisa Ridolfo, Elisa Garlassi, Clara Schiantarelli, Rossella Fisichella, Salvatore Berretta, Francesco Basile, Guglielmo Nasti, Massimiliano Berretta, Immacolata Izzi, Vincenzo Montesarchio, Giuseppe Nunnari, Bruno Cacopardo, Renato Talamini, Michele Spina, Alessandra Bearz, Alessandro Cappellani and Arben Lleshi
DOI: 10.2174/157016210791111061
A Highly Concentrated and Taste-Improved Aqueous Formulation of Efavirenz for a More Appropriate Pediatric Management of the Anti-HIV Therapy
, 8(3): 223 - 231Diego A. Chiappetta, Christian Hocht and Alejandro Sosnik
DOI: 10.2174/157016210791111142
Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model
, 8(3): 232 - 239Catherine L. Cherry, Masqura Mobarok, Steven L. Wesselingh, Randi Fain, Shelley Weinstock, Gilda Tachedjian, Seema Srivastava, David P. Tyssen, Jonathan D. Glass and David J. Hooker
DOI: 10.2174/157016210791111106
The Vpu Protein: New Concepts in Virus Release and CD4 Down-Modulation
, 8(3): 240 - 252Autumn Ruiz, John C. Guatelli and Edward B. Stephens
DOI: 10.2174/157016210791111124
The TLR4 ASP299GLY Polymorphism is a Risk Factor for Active Tuberculosis in Caucasian HIV-Infected Patients
, 8(3): 253 - 258Ildefonso Pulido, Manuel Leal, Miguel Genebat, Yolanda M. Pacheco, Maria Eugenia Saez and Natalia Soriano-Sarabia
DOI: 10.2174/157016210791111052
Evidence for Possible Biological Advantages of the Newly Emerging HIV-1 Circulating Recombinant Form from Malaysia - CRF33_01B in Comparison to its Progenitors _ CRF01_AE and Subtype B
, 8(3): 259 - 271Katherine A. Lau, Bin Wang, Monica Miranda-Saksena, Ross Boadle, Adeeba Kamarulzaman, Kee-Peng Ng and Nitin K. Saksena
DOI: 10.2174/157016210791111151
Editor-in-Chief
Yuntao Wu
National Center for Biodefense and Infectious Diseases
School of Systems Biology
George Mason University
Manassas, VA
(USA)
Biography
National Center for Biodefense and Infectious Diseases
School of Systems Biology
George Mason University
Manassas, VA
Biography
Biography of Yuntao Wu
Dr. Yuntao Wu is a professor at the National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA. He received his Ph.D. from the Department of Microbiology and Immunology at Queen’s University, Kingston, Ontario, Canada, and his postdoctoral training at NIH, Bethesda, Maryland, USA. Dr. Wu studies HIV infection of blood CD4 T cells and macrophages (Science, 2001, 293:1503-6), mainly focusing on the role of chemokine- and HIV-1-mediated G-protein signaling and actin dynamics in HIV infection and pathogenesis (Cell, 2008, 134,782; Science Advances, 2019, 5:1,aat7911). Currently, his lab also studies the mechanisms of PSGL-1 restriction of HIV infection (Nature Microbiology, 2019, 4:813-25).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net